Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: MExiletine Versus Lamotrigine in Non-Dystrophic Myotonias [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mexiletine to lamotrigine in non-dystrophic myotonias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)
  • Mexiletine (Mexiletine)

Snippet

Sponsor: University College, London | Conditions: Non-Dystrophic Myotonia | Phase 3 | Status: UNKNOWN